Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRIM51CP is annotated as a pseudogene within the TRIM family, specifically associated with SPRY domain-containing genes. As a pseudogene, TRIM51CP does not encode a functional protein, and there is no evidence of a direct biological function, disease association, or role as a therapeutic target. Pseudogenes are by definition non-functional genomic DNA sequences similar to functional genes but generally do not express functional proteins. While TRIM family proteins often have E3 ubiquitin ligase activity and are involved in protein-protein interactions via their SPRY or B30.2 domains, pseudogenes like TRIM51CP lack these activities. There is no evidence that TRIM51CP is expressed or has any biological function, nor is it considered a druggable target or biomarker. No disease roles, biological activities, or mechanism of drug interaction are known for this pseudogene. Therefore, TRIM51CP is not a functional protein target, receptor, enzyme, or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing 51C, pseudogene (TRIM51CP).